Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Nigel Walker

Nice Insight

Column: Clinical Trials

How Artificial Intelligence May Drive the Future of Clinical Trials

James Grote

Nice Insight

Column: Regulatory Spotlight

New FDA Guidance on Real World Evidence/Real World Data

David Alvaro, Ph.D.

Pharma's Almanac

Column: New Drug Watch

Alzheimer Drug Still Controversial

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Column: Technology

mRNA Technology: Is the Long Path Behind Leading to Endless Successes Ahead?

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

Column: Investment

2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out

Danielle Alvarez

Pharma's Almanac

Column: Regional

Expanding the Cell and Gene Therapy Ecosystem in Philadelphia

David Alvaro, Ph.D.

Pharma's Almanac

Recombinant Antibody Production

HEK Cells vs. CHO Cells in Recombinant Antibody Production: What's the Better Choice

evitria AG

Biotechs

10 Promising Biotechs Aiming to Transform Medicine

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

Biomanufacturing

Unique Vector Expression Technologies for Boosting Protein Production in E. coli

Trond Erik Vee Aune, Ph.D.

Vectron Biosolutions

Cell Culture

Changing the Future of Cell Culture and Accelerating Next-Generation Therapies

A.J. Mellott, Ph.D.; Scott Leigh

Ronawk

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

Jennifer Chadwick, Ph.D.

ProtaGene

COVID-19 Vaccines

Will the Second Wave of COVID-19 Vaccines Have the Improved Properties Needed to End the Pandemic?

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Process Validation

Streamlining Process Validation for Drug Substance Manufacturing

Gerhard Noessner, Ph.D.; Juergen Utz, Ph.D.; Juergen Bank, Ph.D.

Fareva

Investment

Global Investment Trends and Getting Noticed by PE/VC Firms

Iesan Tsai

Kiri Capital

Sterile

Sterile Injectables Device and Packaging Trends

James Grote

Nice Insight

Mesenchymal Stem Cells

The Exciting Growth Curve for hMSCs Must Be Facilitated by Manufacturing Advances

David Alvaro, Ph.D.

Pharma's Almanac

Solubility

The Limitless Potential of Thin Film Freezing

Glenn Mattes

TFF Pharmaceuticals, Inc.

Neurodegenerative Diseases

Pioneering Nanocatalysis to Revolutionize Treatments for Neurodegenerative Diseases

Rob Etherington

Mesenchymal Stem Cells

Moving Beyond the Industrialization of MSCs

Tim Kelly, Ph.D.

RoosterBio